These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10692996)
1. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Heym B; Saint-Joanis B; Cole ST Tuber Lung Dis; 1999; 79(4):267-71. PubMed ID: 10692996 [No Abstract] [Full Text] [Related]
2. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272 [TBL] [Abstract][Full Text] [Related]
3. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Zhang Y; Heym B; Allen B; Young D; Cole S Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713 [TBL] [Abstract][Full Text] [Related]
4. [A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains]. Homorodean D Pneumologia; 2005; 54(2):58-61. PubMed ID: 16536002 [TBL] [Abstract][Full Text] [Related]
5. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire). N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272 [No Abstract] [Full Text] [Related]
6. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. Yu S; Girotto S; Lee C; Magliozzo RS J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821 [TBL] [Abstract][Full Text] [Related]
7. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T. Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090 [TBL] [Abstract][Full Text] [Related]
8. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Zhang Y; Garbe T; Young D Mol Microbiol; 1993 May; 8(3):521-4. PubMed ID: 8392139 [TBL] [Abstract][Full Text] [Related]
9. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314 [TBL] [Abstract][Full Text] [Related]
10. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions]. Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935 [TBL] [Abstract][Full Text] [Related]
11. Kat G mutations in isoniazid resistant Mycobacterium tuberculosis isolates from Thai patients. Paca-uccaralertkun S; Chuchottaworn C Southeast Asian J Trop Med Public Health; 1997 Jun; 28(2):387-90. PubMed ID: 9444026 [TBL] [Abstract][Full Text] [Related]
12. The tuberculosis prodrug isoniazid bound to activating peroxidases. Metcalfe C; Macdonald IK; Murphy EJ; Brown KA; Raven EL; Moody PC J Biol Chem; 2008 Mar; 283(10):6193-200. PubMed ID: 18056997 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of katG codon 315 mutations among isoniazid sensitive and resistant mycobacterium tuberculosis isolates from Thailand. Imwidthaya P; Mieskes K; Rienthong S J Med Assoc Thai; 2001 Jun; 84(6):864-9. PubMed ID: 11556467 [TBL] [Abstract][Full Text] [Related]
14. Two [Fe(IV)=O Trp*] intermediates in M. tuberculosis catalase-peroxidase discriminated by multifrequency (9-285 GHz) EPR spectroscopy: reactivity toward isoniazid. Singh R; Switala J; Loewen PC; Ivancich A J Am Chem Soc; 2007 Dec; 129(51):15954-63. PubMed ID: 18052167 [TBL] [Abstract][Full Text] [Related]
15. The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. Slayden RA; Barry CE Microbes Infect; 2000 May; 2(6):659-69. PubMed ID: 10884617 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. Negi SS; Anand R; Pasha ST; Gupta S; Basir SF; Khare S; Lal S Indian J Exp Biol; 2006 Jul; 44(7):547-53. PubMed ID: 16872043 [TBL] [Abstract][Full Text] [Related]
17. Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Saint-Joanis B; Souchon H; Wilming M; Johnsson K; Alzari PM; Cole ST Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):753-60. PubMed ID: 10051449 [TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid]. Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428 [TBL] [Abstract][Full Text] [Related]
19. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. van Soolingen D; de Haas PE; van Doorn HR; Kuijper E; Rinder H; Borgdorff MW J Infect Dis; 2000 Dec; 182(6):1788-90. PubMed ID: 11069256 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of catalase and peroxidase activity of tubercle bacilli sensitive and resistant to INH]. Litwin B; Srednicka-Zajac D; Przemyska B Gruzlica; 1968 Jun; 36(6):505-8. PubMed ID: 4970097 [No Abstract] [Full Text] [Related] [Next] [New Search]